ARCHIVES

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

In Congress: Conferees Approve 42 billion Increase For NIH Appropriations

October 29, 1999

Funding Opportunities: PAs Available.

January 28, 2005

RG7204 Meets Endpoints Of Extending Survival, PFS

February 25, 2011

Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals

October 10, 2014

Foon To Direct Barrett Center; Hundahl Leads Commission

March 5, 1999

NCI Advisory Group, Other Cancer Meetings

July 25, 1986